Stay updated on Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial
Sign up to get notified when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.

Latest updates to the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page
- Check6 days agoChange DetectedThe Record History now includes a new revision entry (v3.3.2) and the previous revision (v3.3.1) has been removed. This change only affects version tracking rather than any study data, results, or core page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision labels show a new revision (v3.3.1) added and a previous revision (v3.2.0) removed on the Record History page, which are minor versioning updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe government funding notice banner at the top of the page has been removed. Previously, it informed users about potential delays in updates due to funding.SummaryDifference0.7%

- Check35 days agoChange DetectedThe new screenshot shows a very similar Record History table with the same sections and data; no critical fields or values appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference12%

- Check71 days agoChange DetectedUpgrade noted: version updated from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.